Business · 19/10/2023Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Eight Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of eight abbreviated new drug applications (ANDAs) from multiple applicants, following a request from the applicants to discontinue marketing of the drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →